|
|
||||||||
Ann Thorac Surg 2000;69:1993-1994
© 2000 The Society of Thoracic Surgeons
a Azienda Ospedaliera, San Giovanni Battista di Torino, Cardiochirurgia Universitaria, C. so Dogliotti, 14, 10126 Torino, Italy
e-mail: actisdato{at}hotmail.com
To the Editor
Transmyocardial revascularization (TMR) has been recently approved to be a safe and effective method in case of recurrent angina after a previous direct revascularization or in case of aggressive progression of the coronary disease with contraindication to bypass or percutaneous transluminal coronary angioplasty procedures. A clinical improvement in Canadian class of TMR patients is a well-known result when compared with medical therapy alone [1]. Reading the excellent paper by Agarwal and colleagues [2] and the interesting invited commentary by March in which a combined TMR plus coronary artery bypass graft procedure in case of limited native coronary bed is indicated in order to reduce perioperative risk, we would add our personal experience.
We started a TMR program in 1996, and since this date 20 patients (13 males; mean age 66 ± 0.7 years) received a surgical procedure using an Holmium:YAG laser (Eclipse 2000). Our policy was to propose and to perform TMR only in patients with a Canadian class III to IV and with no indications to receive a direct revascularization (Table 1). In our series, clinical results were comparable with the literature but perfusion test did not show a significative improvement at follow-up. Nevertheless, we observed the following significative case.
|
A diffuse coronary disease similar to the prebypass study and a patency of both arterial and venous graft but a reduced run-off possibly due to the microvessel disease was present. A TMR was then performed after a scintigraphic basal evaluation (Fig 1). The procedure, performed in the usual manner, was uneventful and the patient was discharged 7 days after intervention in Canadian class I. A perfusion scan with Tallium was then performed 4 months after surgery and revealed a complete absence of deficit after stress (Fig 2).
|
|
In conclusion, we agree with the idea that a combined effect of direct revascularization associated with TMR should be effective to improve perfusion and to reduce operative risk in a large patient population affected by diffuse coronary disease, and this can be more true in cases in which a microvessel disease is present (ie, diabetes).
References
Related Article
This article has been cited by other articles:
![]() |
K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |